نتایج جستجو برای: brca1

تعداد نتایج: 8182  

Journal: :Cancer research 2010
Ekaterina P Lamber Andrew A Horwitz Jeffrey D Parvin

BRCA1, the breast cancer- and ovarian cancer-specific tumor suppressor, can be a transcriptional repressor or a transcriptional activator, depending on the promoter context. To identify the genes activated or repressed by BRCA1, we have analyzed microarray results from cells depleted of BRCA1 and revealed a number of genes regulated by BRCA1 on the level of transcription. Among the genes repres...

2016
C. Winter M. P. Nilsson E. Olsson A. M. George Y. Chen A. Kvist T. Törngren J. Vallon-Christersson C. Hegardt J. Häkkinen G. Jönsson D. Grabau M. Malmberg U. Kristoffersson M. Rehn S. K. Gruvberger-Saal C. Larsson Å. Borg N. Loman L. H. Saal

BACKGROUND A mutation found in the BRCA1 or BRCA2 gene of a breast tumor could be either germline or somatically acquired. The prevalence of somatic BRCA1/2 mutations and the ratio between somatic and germline BRCA1/2 mutations in unselected breast cancer patients are currently unclear. PATIENTS AND METHODS Paired normal and tumor DNA was analyzed for BRCA1/2 mutations by massively parallel s...

مقدمه:سرطان پستان، شایع‌ترین بدخیمی در زنان و به‌‌عنوان اولین علت مرگ‌و‌میر ناشی از سرطان در زنان شناخته می‌شود.این بیماری به شدت ناهمگن بوده و تحت تأثیر عوامل ژنتیکی و محیطی به‌وجود می‌آید. جهش در دو ژن بسیار پرنفوذ BRCA1 و BRCA2 که نقش مهمی در ترمیم DNA دارند، علت اصلی 30-20% سرطان‌های پستان ارثی شناخته شده است. مطالعه حاضر با هدف بررسی فراوانی جهش‌های ژن BRCA1 در افراد مبتلا به سرطان پستان د...

2011
Olafur Andri Stefansson Jon Gunnlaugur Jonasson Kristrun Olafsdottir Holmfridur Hilmarsdottir Gudridur Olafsdottir Manel Esteller Oskar Thor Johannsson Jorunn Erla Eyfjord

Triple-negative breast cancer (TNBC) occurs in approximately 15% of all breast cancer patients, and the incidence of TNBC is greatly increased in BRCA1 mutation carriers. This study aimed to assess the impact of BRCA1 promoter methylation with respect to breast cancer subtypes in sporadic disease. Tissue microarrays (TMAs) were constructed representing tumors from 303 patients previously screen...

Journal: :The Journal of biological chemistry 2002
Qing Zhong Chi-Fen Chen Phang-Lang Chen Wen-Hwa Lee

BRCA1 is critical for the maintenance of genomic stability, in part through its interaction with the Rad50.Mre11.Nbs1 complex, which occupies a central role in DNA double strand break repair mediated by nonhomologous end joining (NHEJ) and homologous recombination. BRCA1 has been shown to be required for homology-directed recombination repair. However, the role of BRCA1 in NHEJ, a critical path...

Journal: :Cancer research 2000
R L Baldwin E Nemeth H Tran H Shvartsman I Cass S Narod B Y Karlan

There is a clear association between germ-line BRCA1 mutations and inherited ovarian cancer; however, the association between BRCA1 mutations and sporadic ovarian cancer remains ambiguous. The frequency of BRCA1 promoter hypermethylation as an epigenetic means of BRCA1 inactivation was determined for a large, population-based cohort of ovarian cancer patients. BRCA1 promoter hypermethylation wa...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003
Sophie M Ginolhac Sophie Gad Marilys Corbex Brigitte Bressac-De-Paillerets Agnès Chompret Yves-Jean Bignon Jean-Philippe Peyrat Joelle Fournier Christine Lasset Sophie Giraud Danièle Muller Jean-Pierre Fricker Agnès Hardouin Pascaline Berthet Christine Maugard Catherine Nogues Rosette Lidereau Michel Longy Sylviane Olschwang Christine Toulas Rosine Guimbaud Drakoulis Yannoukakos Csilla Szabo Francine Durocher Anne-Marie Moisan Jacques Simard Sylvie Mazoyer Henry T Lynch David Goldgar Dominique Stoppa-Lyonnet Gilbert M Lenoir Olga M Sinilnikova

Strong inter- and intrafamilial variation of penetrance of breast and ovarian cancer is observed in BRCA1 mutation carriers. The wild-type copy of the BRCA1 gene is a plausible candidate as a cancer risk modifier given that the residual function corresponding to the intact BRCA1 allele may influence the process of tumor formation in BRCA1 carriers. Indeed, growing evidence is now becoming avail...

ژورنال: پژوهش در پزشکی 2007
محرابی, یدالله, نقوی, بهار, علوی مجد, حمید, واحدی, محسن,

Background: Microarray DNA technology has paved the way for investigators to expressed thousands of genes in a short time. Analysis of this big amount of raw data includes normalization, clustering and classification. The present study surveys the application of clustering technique in microarray DNA analysis. Materials and methods: We analyzed data of Van’t Veer et al study dealing with BRCA1...

2015
QIUYUN LI WEI WEI YI JIANG HUAWEI YANG JIANLUN LIU

BRCA1 is a susceptibility gene that has a genetic predisposition for breast cancer. BRCA1 gene mutation is closely associated with familial hereditary breast cancer, but the BRCA1 gene mutation is rarely found in sporadic breast cancer. According to previous studies, decreased expression of BRCA1 was detected in certain types of sporadic breast cancer. Aberrant methylation of DNA promoter CpG i...

2012
Yoshiko Shimizu Hugh Luk David Horio Penelope Miron Michael Griswold Dirk Iglehart Brenda Hernandez Jeffrey Killeen Wael M. ElShamy

INTRODUCTION Women with HER2(+) or triple negative/basal-like (TN/BL) breast cancers succumb to their cancer rapidly due, in part to acquired Herceptin resistance and lack of TN/BL-targeted therapies. BRCA1-IRIS is a recently discovered, 1399 residue, BRCA1 locus alternative product, which while sharing 1365 residues with the full-length product of this tumor suppressor gene, BRCA1/p220, it has...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید